Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B... (

Human Genome Sciences Completes Enrollment in First of Two Phase 3 Lymphostat-B(R) Trials

Date:4/22/2008

- Completion of enrollment in second Phase 3 trial expected by end of

summer -

- First Phase 3 data now expected by mid-2009, with all Phase 3 data

expected in fall 2009 -

ROCKVILLE, Md., April 22 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced that it has completed enrollment and initial dosing in BLISS-52, one of two pivotal Phase 3 clinical trials of LymphoStat-B(R) (belimumab) in patients with active systemic lupus erythematosus (SLE). LymphoStat-B is being developed by HGS and GlaxoSmithKline (GSK) under a co-development and commercialization agreement entered into in August 2006.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

"We continue to be excited by LymphoStat-B's potential. Assuming it is successful in Phase 3, we believe that LymphoStat-B could represent a breakthrough in the treatment of SLE," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "With enrollment now completed in the BLISS-52 trial, we are on track to have our first Phase 3 data for LymphoStat-B available by mid-2009, and all Phase 3 data available in fall 2009."

BLISS-52 was initiated in May 2007, and has enrolled and randomized a total of 867 patients at 90 clinical sites in 13 countries, primarily in Asia, South America and Eastern Europe. Completion of enrollment for the other pivotal Phase 3 trial of belimumab, BLISS-76, is expected by the end of summer 2008. BLISS-76, which was initiated in February 2007, is being conducted primarily in North America and Europe, and will enroll and randomize a minimum of 810 sub
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6
Related medicine technology :

1. Tepha Announces First Human Usage of Medical Devices Derived from New Class of Resorbable Polymers
2. Data Show SuperGens MP-470 is Safe in Humans
3. Longevinex(R) Found to be Superior to Green Tea Molecule in Independent Human Study
4. CardioMind Launches First-in-Human Trial of Small Vessel, Drug-Eluting Stent
5. Gen-Probe Begins U.S. Clinical Study of Molecular Test for Human Papillomavirus, Which Causes Cervical Cancer
6. ExonHits EHT 0202 Counters Scopolamines Detrimental Effects on Cognition in Humans
7. Valor Medical Announces First Human Implant of Neucrylate AN(TM) for Treatment of Cerebral Aneurysm
8. Synbiotics Corporation Announces Human Submission for FluDetect(R)
9. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
10. Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
11. N30 Pharma Announces Successful Initiation of Human Studies With N30-201

Post Your Comments:

(Date:5/16/2013)... , May 16, 2013 HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013. The conference is being ... A live webcast of the Company,s presentation at ...

(Date:5/16/2013)... , May 16, 2013 Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...

(Date:5/16/2013)... -- OrthoView PSL will allow individual surgeons ... widely-used OrthoView digital templating software via the Cloud and ... started. OrthoView, the leading independent provider of ... dedicated to enabling orthopaedic surgeons in hospitals and private ... film is unavailable. Over 5,000 orthopaedic surgeons in the ...

Breaking Medicine Technology:HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2 OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2

[0] HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast [0] Amgen To Present At The UBS Global Life Sciences Conference [0] OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons

... Medical, Inc. (OTCBB: AEMD), the pioneer in developing ... cancer, announced today the introduction of HER2osome™, a ... of HER2+ breast cancer, which is characterized by ... over-expression of HER2 protein. Breast cancer represents the ...

... Sept. 21, 2011 Reportlinker.com announces that a ... catalogue: Generic Drugs: The ... http://www.reportlinker.com/p0619264/Generic-Drugs-The-Global-Market-Focus-on-the-Americas.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment ... examination of the strategies employed by companies specializing ...

Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer Generic Drugs: The Global Market: Focus on the Americas

(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...

(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...

(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...

(Date:5/18/2013)... 2013 As metal-on-metal hip implant ... country, Bernstein Liebhard LLP notes that a new study ... tissue damage before they experience any pain from a ... Daily will appear in the Journal of Bone & ... screens of their hips. The researchers found tissue ...

(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, ... Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive ... major market drivers, restraints, and opportunities in North America, ... , 147 market data tables ... 318 pagesand in-depth TOC of “Sleep Apnea ...

Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3 Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2 Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3 Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2 Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3 Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4 Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2 Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3

[0] Consuming coffee linked to lower risk of detrimental liver disease, Mayo Clinic finds [0] Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces [0] Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets [0] Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients [0] Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets

... at the Queensland Institute of Medical Research (QIMR) and the ... and successfully treated it by performing an experimental stem cell ... and out of hospital Katie Pulling had almost given up ... hearing the doctors say, ,We don,t know what is wrong, ...

... the forefront of HIV prevention research will be taking center ... L. Lawrence Convention Center in Pittsburgh May 22-25. M2010 ... community advocates and experts in global health who are working ... of the world. Nearly 1,000 participants from 47 countries will ...

... ... to look for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very ... ... you don’t know what to look for. A torque screwdriver comes in many different ...

... controlled severe disease using less medication , MONDAY, May ... be a mouse click away, Dutch researchers report. , ... program maintained long-term control of severe asthma but needed ... do so, the study found. , "We know that ...

... researchers say , MONDAY, May 17 (HealthDay News) -- ... organophosphate pesticides, commonly found on berries, celery and other ... (ADHD) in children. , At this point, though, there ... ADHD, stated the authors of a paper appearing in ...

... Fighting ... takes is one look at the brand and the name to get an instant smile and chuckle. ... , ... Drink (FCE) is a concept that was born on the cusp of the energy drink boom that ...

Cached Medicine News:Health News:Australian researchers identify a new disease 2 Health News:Press briefings at International Microbicides Conference May 22-25 2 Health News:Press briefings at International Microbicides Conference May 22-25 3 Health News:Press briefings at International Microbicides Conference May 22-25 4 Health News:Press briefings at International Microbicides Conference May 22-25 5 Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2 Health News:Web-Based Program Can Boost Asthma Care 2 Health News:Pesticides on Produce Tied to ADHD in Children 2 Health News:Pesticides on Produce Tied to ADHD in Children 3 Health News:Unique Marketing Approach to the Energy Drink Market Brings Explosive Response 2

Australian researchers identify a new disease Press briefings at International Microbicides Conference May 22-25 Flexible Assembly Systems Announces Torque Screwdriver Application Guide Web-Based Program Can Boost Asthma Care Pesticides on Produce Tied to ADHD in Children Unique Marketing Approach to the Energy Drink Market Brings Explosive Response

... Our Buffered Wright-Giemsa Stain is ... contains the fixative, buffer, and ... staining of blood smears. It ... bottle for ease of use ...

This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....

Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast....

Albumin (BCP). Storage temp: 15 - 30 C. Linearity: 0.5 - 8.0 g/dl. Expected values: 3.5 - 5.5 g/dl. Available with calibrator. Performs 250 number of tests....

Medicine Products:

Buffered Wright-Giemsa Stain Wright-Giemsa Stain Wright stain Albumin (BCP)